The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.


Download and Print: Download Printer-friendly PDF Download data


Figure 1.17

CSR Figure 1.17: SEER Incidence, Burden vs Risk by Cancer Site


Figure 1.17

Incidence Percent Change between 2008 and 2017
Numbers (burden) vs Rates (risk)
All Races, All Ages, Both Sexes

Cancer Site Burden Percent ChangeRisk Percent Change
Liver & IBD 35.4 9.9
Melanoma of the Skin 28.0 8.7
Corpus & Uterus, NOS 28.1 7.9
Thyroid 16.6 6.5
Myeloma 28.5 6.1
Testis 10.0 4.4
Pancreas 25.1 2.3
Oral Cavity & Pharynx 22.1 2.2
Kidney & Renal Pelvis 21.0 1.7
Breast (Female) 15.9 0.9
Leukemia 12.4 -4.0
Stomach 12.8 -6.1
Cervix Uteri -1.0 -7.8
Brain & ONS 4.5 -8.3
Non-Hodgkin Lymphoma 8.3 -8.9
All Cancer Sites 8.4 -9.6
Urinary Bladder 7.6 -12.4
Esophagus 5.4 -14.5
Hodgkin Lymphoma -10.5 -17.3
Lung & Bronchus 1.0 -18.5
Ovarya -8.1 -20.0
Colon & Rectum -5.3 -20.5
Larynx -7.9 -25.0
Prostate -5.9 -27.5

Footnotes:

Source: SEER 21 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, San Jose-Monterey, Los Angeles, Alaska Native Registry, Rural Georgia, California excluding SF/SJM/LA, Kentucky, Louisiana, New Jersey, Georgia excluding ATL/RG, Idaho, New York and Massachusetts).

Burden is the change in the number of incidence cases between 2008 and 2017.

Risk is the change in the cancer incidence rates between 2008 and 2017.

aOvary excludes borderline cases or histologies 8442, 8451, 8462, 8472, and 8473.

Page Navigation: << Previous Next >>


The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.